ProPhase Labs, Inc. (PRPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 50M 100M 150M Q3 '20: 12.5M Q4 '20: 14.5M Q1 '21: 27.9M Q2 '21: 33.4M Q3 '21: 39M Q4 '21: 79M Q1 '22: 111.3M Q2 '22: 131.3M Q3 '22: 146M Q4 '22: 122.6M Q1 '23: 94.4M Q2 '23: 78.5M Q3 '23: 62.7M Q4 '24: 6.8M Q1 '25: 5.8M Q2 '25: 5.6M Q3 '25: 5.1M Q4 '25: 4.3M Q1 '26: 4.1M Q2 '26: 3.8M Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-30M 0 30M 60M 90M Q3 '20: 3.7M Q4 '20: 4.6M Q1 '21: 13.1M Q2 '21: 16.3M Q3 '21: 19.2M Q4 '21: 42M Q1 '22: 61.7M Q2 '22: 76M Q3 '22: 84M Q4 '22: 70.7M Q1 '23: 52.5M Q2 '23: 40.2M Q3 '23: 30.6M Q4 '24: -150K Q1 '25: 436K Q2 '25: 1.3M Q3 '25: 987K Q4 '25: 1.4M Q1 '26: 1.2M Q2 '26: 645K Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '20: -1.8M Q4 '20: -2.1M Q1 '21: -48K Q2 '21: -1.6M Q3 '21: -4.6M Q4 '21: 9.8M Q1 '22: 24.7M Q2 '22: 36.8M Q3 '22: 42.4M Q4 '23: -21.2M Q1 '24: -29.7M Q2 '24: -32.3M Q3 '24: -32.3M Q4 '24: -38.6M Q1 '25: -34.7M Q2 '25: -31.3M Q3 '25: -29.6M Q4 '25: -18M Q1 '26: -16.8M Q2 '26: -15.6M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '20: -1.6M Q4 '20: -2.1M Q1 '21: -259K Q2 '21: -1.7M Q3 '21: -5.3M Q4 '21: 6.3M Q1 '22: 17.7M Q2 '22: 26.6M Q3 '22: 31.5M Q4 '23: -16.8M Q1 '24: -23.6M Q2 '24: -26.3M Q3 '24: -27.8M Q4 '24: -53.4M Q1 '25: -43.1M Q2 '25: -41.5M Q3 '25: -41.7M Q4 '25: -14.7M Q1 '26: -23.9M Q2 '26: -22.5M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 25M 50M 75M Q3 '20: 8.8M Q4 '20: 9.9M Q1 '21: 14.8M Q2 '21: 17.1M Q3 '21: 19.8M Q4 '21: 37.1M Q1 '22: 49.6M Q2 '22: 55.3M Q3 '22: 62M Q4 '22: 52M Q1 '23: 41.9M Q2 '23: 38.3M Q3 '23: 32.1M Q4 '24: 6.9M Q1 '25: 5.4M Q2 '25: 4.3M Q3 '25: 4.1M Q4 '25: 3M Q1 '26: 2.9M Q2 '26: 3.2M Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-20M -10M 0 10M 20M 30M Q3 '20: 3.7M Q4 '21: -13.6M Q1 '22: 14.6M Q2 '22: 14.9M Q3 '22: 23.1M Q4 '22: 28.6M Q1 '23: 8.7M Q2 '23: -3M Q3 '23: -10.3M Q4 '23: -11.9M Q1 '24: -17.5M Q2 '24: -15.4M Q3 '24: -14.8M Q4 '24: -17.5M Q1 '25: -15.8M Q2 '25: -11.2M Q3 '25: -10.6M Q4 '25: -8.3M Q1 '26: -5.7M Q2 '26: -5.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-27M -18M -9M 0 9M 18M 27M Q1 '20: -2.3M Q2 '20: 3M Q3 '20: 3.5M Q4 '21: -17.9M Q1 '22: 13.2M Q2 '22: 13.2M Q3 '22: 20.8M Q4 '22: 24.6M Q1 '23: 5.4M Q2 '23: -6.4M Q3 '23: -13.8M Q4 '23: -14M Q1 '24: -19.9M Q2 '24: -17.2M Q3 '24: -15.9M Q4 '24: -18.4M Q1 '25: -15.8M Q2 '25: -11.2M Q3 '25: -10.7M Q4 '25: -8.3M Q2 '20 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '19: 11.6K Q1 '20: 11.6M Q2 '20: 11.6K Q1 '21: 18.2K Q2 '21: 15.2K Q3 '21: 15.4K Q1 '22: 18.7K Q2 '22: 19.3K Q3 '22: 20.2M Q1 '23: 18.1M Q2 '23: 16.8M Q3 '23: 17.2M Q1 '24: 17.2M Q2 '24: 18.9M Q3 '24: 19.1M Q1 '25: 3.5M Q2 '25: 4.2M Q3 '25: 41.5M Q1 '26: 12.3M Q2 '26: 14M Q1 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-30.00 -20.00 -10.00 0.00 10.00 20.00 30.00 Q1 '11: -0.24 Q3 '12: 0.13 Q4 '12: 0.29 Q4 '23: -0.98 Q1 '24: -1.37 Q2 '24: -1.50 Q3 '24: -1.55 Q4 '24: -26.70 Q1 '25: -25.21 Q2 '25: -25.96 Q3 '25: -25.77 Q4 '25: -1.66 Q1 '26: -3.21 Q2 '26: -2.35 Q3 '12 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.